Abstract Platelet-rich fibrin (PRF) has been used in regenerative medicine and dentistry. Recently, its use has been advocated for regenerative periodontics and wound healing. The randomized control trials have assessed the regenerative efficacy of the PRF for restoring intrabony periodontal defects. The objectives are to critically analyze and appraise the currently available literature, focusing on the use of PRF in regenerating periodontal bone defects. An electronic search was conducted (PubMed/MEDLINE, Google Scholar, ISI-WOS). Various combinations of following keywords were used: 'platelet-rich fibrin', 'intrabony', 'periodontal', 'bone defect' and 'guided tissue regeneration'. A secondary search was conducted by analyzing the reference lists of the articles obtained in initial search. The final search resulted in 13 randomized controlled trials being included. In majority of studies, PRF resulted in better clinical/radiographic outcomes than open flap debridement and augmented therapeutic effects of bone grafts. The combination of bovine bone substitutes and PRF resulted in better performance compared to alone. Similarly better outcomes were observed while using PRF in combination with nanohydroxyapatite, metformin and demineralized freeze-dried bone allograft. It can be concluded that PRF produces better outcomes than open flap debridement alone and augments the regenerative effects of bone substitutes.
Introduction
Platelet-rich plasma (PRP) is autologous plasma which has been enriched with platelets and leukocytes in addition to jellifying agents, growth factors, cytokines, bovine thrombin, and anticoagulants [1, 2] . PRP has been employed in regenerative medicine to promote wound healing and tissue regeneration [3, 4] . However, PRP has some reported limitations [5] for example, growth factors are released for only a very short period of time. In addition, there are concerns such as the bovine clotting factors may react with human clotting factors to give rise to bleeding. More recently, a second generation platelet derivative, called platelet-rich fibrin (PRF), has been used in regenerative medicine and dentistry [6] [7] [8] . PRF is produced by slow centrifugation of blood and it contains a high number of platelets and leukocytes in addition to the dense fibrin matrix. The fibrin matrix and platelets contribute to wound healing while leukocytes contribute to the anti-bacterial effects. Unlike PRP, PRF contains a fibrin matrix instead of jellifying agents and bovine clotting factors [9] . Hence, the chances of coagulopathies are minimized. Furthermore, PRF exhibits a slow and sustained release of growth factors, such as transforming growth factor-b1, platelet-derived growth factor, and vascular endothelial growth factor which all have been proven to promote the wound healing and tissue regeneration [8, 10] .
Guided tissue regeneration (GTR) involves the placement of synthetic and natural barrier membranes and bioactive materials to stimulate the regeneration of periodontal bone and promote healing of periodontal bone defects [11] [12] [13] [14] . It has been established in numerous randomized control trials (RCTs) that using biodegradable GTR materials along with open flap debridement (OFD) results in superior outcomes compared to OFD alone [15, 16] . However, these materials have a number of drawbacks including poor biomechanical properties, risk of infection, hypersensitivity reactions, and ethical concerns [17, 18] . Because of its regenerative capabilities, human origin, and absence of animal growth factors, PRF has been used in regenerative dentistry applications [19, 20] . More recently, its use has been advocated for regenerative periodontics and wound healing [21] . Some in vitro and in vivo studies have shown that PRF promotes the proliferation and differentiation of periodontal tissues along with angiogenesis [22, 23] . Furthermore, randomized control trials have assessed the efficacy of PRF for restoring intrabony periodontal defects [24, 25] . The objectives of this review are to critically analyze and appraise the currently available literature, focusing on the use of platelet-rich fibrin and the outcomes in restoring and regeneration of periodontal intrabony defects.
Focus question
In patients with intrabony periodontal defects, what is the effect of using PRF-based grafts on the clinical and radiographic outcomes?
2 Materials and methods
Search methodology
An electronic search was conducted via PubMed/MED-LINE, Google Scholar and ISI Web of Science databases for studies published from 1949 to January 2016. Various combinations of following keywords were used: 'plateletrich fibrin', 'intrabony', 'periodontal', 'bone defect' and 'guided tissue regeneration'. All the authors conducted the search individually and analyzed the titles and abstracts to select the studies according to the inclusion/ exclusion criteria described below. A secondary search was conducted by analyzing the reference lists of the articles obtained in the initial search. Only English language publications were considered. The search methodology is illustrated in Fig. 1 .
Inclusion and exclusion criteria
The following three inclusion criteria were used: (1) randomized control trials, (2) restoration of bony periodontal defects, and (3) PRF as test intervention. Letters to the editors, commentaries, animal studies, and in vitro studies were excluded.
Quality assessment of randomized control trials
Using the Jadad scale for the quality assessment of control trials [26] , the randomized control trials (RCTs) were assigned scores according to blinding, randomization and the description of the patients treated by authors. If the study was double-blinded, a point was given. Randomization of subjects also warranted a point. Additional points were given if methods of blinding and randomization were described. If an account of all patients was provided, a Fig . 1 Flow chart of the article selection process for this review point was given, correspondingly. Hence, a total score out of 5 points was given to each study.
Results

General characteristics and outcomes of clinical studies
The primary search resulted in 21 articles, out of which 13 were randomized control trials that met the inclusion criteria of this review [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . A total of 8 articles were excluded. No additional articles were found after carrying out the secondary search. The number of patients treated were ranged from 10 to 136 and the number of defects ranged from 20 to 120 [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . Only one study included smokers in the treatment groups [30] . Six studies used OFD as the control intervention [24, 31, [33] [34] [35] [36] , and two studies used PRF as the control [30, 32] . Demineralized freeze-dried bone allograft (DFDBA) was used as the control by two studies [27, 37] . Enamel matrix derivative (EMD) [29] , nano-crystalline hydroxyapatite (nHAp) [28] , and bovine bone xenograft (BBX) [25] were used by one study each. Eleven studies used PRF at least in one test intervention group [24, 25, 27-29, 31, 33-37] , and seven studies used PRF in combination with other GTR materials in the test groups [24, 25, 27, 28, 30, 32, 37] . In addition, the follow-up time ranged from 30 days to 12 months [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . The general characteristics of the studies are detailed in Table 1 and the changes in the clinical and radiographic parameters are summarized in Table 2 .
Measurement of clinical and radiographic parameters
In all studies, the clinical and radiographic parameters were recorded at baseline and follow-up along with their mean differences [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . The pocket depth (PD) and clinical/relative attachment levels (CAL/RAL) were measured in all thirteen studies [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . The sulcular bleeding index (SBI) was measured in five studies [25, 27, 34, 35, 37] . The plaque indexed (PI) was measured in eight studies [24, 25, 27, 28, [34] [35] [36] [37] . The gingival marginal level and recession (GML/REC) were measured in eight studies [24, 27, 30, [32] [33] [34] [35] 37] . The proportion of defect fill (DF) was measured in eight studies [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . The intrabony pocket depth (IBD) was measured in six studies [25, 29, 31, 33, 35, 36] . The radiographic bone levels (RBL), alveolar crest resorption (ACR), and healing index (HI) were measured in one study each [28, 31, 38] . The plaque index was measured in eight studies [24, 25, 27, 28, [34] [35] [36] [37] . One study measured the levels of vascular endothelial growth factor (VEGF) and platelet derived growth factor (PGDF) in the gingival crevicular fluid [25] .
Main outcomes of studies
Compared with OFD alone, PRF combined with OFD resulted in significantly improved clinical and radiographic outcomes in six studies [24, 31, 33, 35, 36, 38] . When combined with the bovine bone substitutes, PRF resulted in better performance outcomes as opposed to when used alone [25, 30] . Similar outcomes were observed when PRF was used in combination with DFDBA in one study [37] . However, in another study, no significant differences were observed between PRF and PRF-DFDBA [32] . Better outcomes were observed when PRF-nHAp was used [28] . PRF augmented the effects of ABG in one study [36] . Similar effect was observed when PRF was combined with metformin (MF) [24] . No significant differences were observed between the outcomes of using PRF or PRP [31] . There was no difference between the PD and CAL when PRF and EMD were contrasted and compared but a higher DF percentage was recorded [29] . The mean changes in IBD, PD, DF and CAL are presented in Table 2 .
Results of the quality assessment of studies
Only one study scored a perfect 5 points out of 5 [30] , 3 points were assigned to one study [34] (35), two studies scored 4 [31, 37] , and seven studies scored 2 points [24, 25, 32, 33, 35, 36] . One point was awarded to three studies each [27] [28] [29] . Patients were randomized into their respective intervention groups in all studies [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] with three studies failing to provide and describe the method of randomization [27] [28] [29] [30] . Adequate doubleblinding was employed in only three studies [24, 30, 37] . Accounts of all patients treated were provided in only two studies [30, 34] . The results of the quality assessment are shown in Table 3 .
Discussion
Autologous plasma derivatives have been used in medicine and dentistry owing to their regenerative abilities [3, 4] . This said, the unique advantage of PRF over conventional plasma derivations such as PRP is that it doesn't contain any bovine derivatives or jellifying agents [9] . Furthermore, PRF is simpler to prepare and relatively inexpensive. Due to the presence of leukocytes, PRF has also been shown to impose an antibacterial effect [39] . Hence, it is not surprising that significantly better clinical radiographic outcomes were observed when PRF were compared with OFD alone [24, 31, [33] [34] [35] [36] . The reduction in PD and IBD upon treatment may be explained by the presence of growth factors present in PRF. However, no difference has been observed between the efficacy and regenerative potential of PRP and PRF [31] even though previous in vitro studies have reported superior results of PRF tested with rat osteoblasts when compared to PRP [40] . From the clinical point of view, the main advantage of PRF over PRP is the superior handling properties than improved efficacy. The PRF can be handled and manipulated similar to conventionally available GTR membranes (Table 3) . Although PRF can mimic and be handled like a GTR membrane, its main disadvantage is that it resorbs in approximately 7 days [30] which is substantially less than [27, 28, 30, 36] . This may be also attributed to osteoconductive effect of the hydroxyapatite present in such bone substitutes [42] . However, the study by Gamal et al. [25] failed to observe any significant difference between the amount of vascular endothelial growth factor (VEGF) as well as plasma derived growth factor (PDGF) released in the defects restored with a combination of PRF and bovine bone. This observation suggests that combined usage of bovine bone and PRF does not have a significant advantage over using bovine bone alone. Nevertheless, the study by Gamal et al. was carried out for only 30 days and on a relatively small sample size. This is why more long-term and large-scale studies are required to further investigate and explain these findings. An addition of 1% MF to PRF has shown substantial advantage in improving clinical and radiographic outcomes after 9 months [24] . Previous studies have also shown that a topical application of 1% MF along with scaling and root planning (SRP) has shown to be more effective in treating periodontitis in smokers than SRP alone [43] . It is noteworthy, however that in the study by Pradeep et al. [24] no statistical difference was observed between the clinical parameters following either MF application or restoring the defect with PRF. That said, the improved efficacy of MF ? PRF may be attributed to the superior bone-fill compared to MF or PRF alone. In the study by Gupta et al. [29] CBCT imaging suggests that EMD is superior compared to PRF in terms of defect resolution. This could be because of the propylene-glycol alginate (PGA) carrier which contains EMD [44] . PGA may provide greater space maintenance than PRF due to its synthetic polymeric structure and, hence, a higher defect resolution. However, more long-term studies are required to investigate this hypothesis. Conversely, a comparison between autologous bone graft (ABG) and PRF has yielded no significant difference between their efficacies albeit more crestal bone loss was observed with ABG [36] . Nevertheless, the short follow-up period (6 months) warrants long-term studies to compare and contrast them.
A major shortcoming among the studies included in this review might be the lack of adequate of follow-up. No study followed-up the patients for more than 12 months [24, 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . Moreover, in none of the studies histological or microbial investigations were conducted. Hence, relying solely on the results of the studies reviewed, the long-term efficacy of PRF and PRF-based combinations cannot be concluded. Additionally, only one of the studies included smokers in the treatment groups which might have led to favorable outcomes in those studies which did not include. Due to short term follow up period of included studies, no significant quantitative data regarding the improvement of intrabony defect can be reported. The quality assessment of the studies revealed a lack of adequate blinding which can be a source of bias in RCTs [26] . Hence, RCTs with longer follow-up periods and better blinding protocols are definitely required to ascertain the long-term efficacy of PRF.
Conclusion
The platelet-rich fibrin when combined with open-flap debridement, produces better outcomes compared to the open flap debridement alone. The regenerative potential of platelet-rich fibrin results in better augmentation and regeneration of periodontal bone defects. In addition, PRF may augment the regenerative potential of bone grafts. However, more long-term and well-designed clinical trials are needed to ascertain the clinical efficacy of platelet-rich fibrin and platelet-rich fibrin containing bone grafts.
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